Keywords: Roche, Fisrt-quarter 2011 financial results
Roche 1st-qtr 2011 sales in line with consensus forecasts
Article | 14 April 2011
Swiss drug major Roche (ROG: VX) has reported first-quarter 2011 sales in-line with consensus estimates, and reiterated guidance for fiscal year 2011. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
